Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides
CA 2399649 A1 · Owner: Arterburn, Matthew C. · Inventors: Drmanac, Radoje T.; Wang, Menq-Yen; Arterburn, Matthew C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human secreted LRR protein-like polypeptide. These polynucleotides comprise nucleic acid sequences isolated from cDNA library from thymus (Hyseq clone identification numbers 16395938 (SEQ ID NO: 1)). Other aspects of the invention include vectors containing processes for producing novel human secreted LRR protein-like polypeptides and antibodies specific for such , polypeptides.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 2, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 2, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 2, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.